Molecular Devices, Agilent Lead Decline in BCW Index | GenomeWeb

Shares in Molecular Devices fell more than 12 percent this past week while Agilent Technologies fell more than 10 percent after the firm reported its fiscal second-quarter earnings. The two firms led an overall decline in the BCW Index of 3.1 percent for the week. Beckman Coulter was the only gainer of the 16 firms in the Index, rising a slim 1.1 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.